StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)

Close on Nov 17, 2026Market cap $82.56BP/E –Yield –

Moderna total assets

Total assets on the balance sheet at the end of each period.

Moderna's total assets was $10.96B at Jun 30, 2026. For fiscal 2025 it was $12.34B, down 12.8% from the year before. The highest annual figure on record is $25.86B in fiscal 2022.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.34B-12.8%
FY2024Dec 31, 2024$14.14B-23.2%
FY2023Dec 31, 2023$18.43B-28.7%
FY2022Dec 31, 2022$25.86B+4.8%
FY2021Dec 31, 2021$24.67B+236.2%
FY2020Dec 31, 2020$7.34B+361.6%
FY2019Dec 31, 2019$1.59B-19.0%
FY2018Dec 31, 2018$1.96B+80.9%
FY2017Dec 31, 2017$1.08B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$10.96B-8.7%
Q1 FY2026Mar 31, 2026$11.49B-9.6%
Q4 FY2025Dec 31, 2025$12.34B-12.8%
Q3 FY2025Sep 30, 2025$12.14B-23.2%
Q2 FY2025Jun 30, 2025$12.01B-23.4%
Q1 FY2025Mar 31, 2025$12.70B-24.1%
Q4 FY2024Dec 31, 2024$14.14B-23.2%
Q3 FY2024Sep 30, 2024$15.80B-18.8%
Q2 FY2024Jun 30, 2024$15.68B-28.3%
Q1 FY2024Mar 31, 2024$16.73B-30.7%
Q4 FY2023Dec 31, 2023$18.43B-28.7%
Q3 FY2023Sep 30, 2023$19.45B-25.4%
Q2 FY2023Jun 30, 2023$21.88B-16.0%
Q1 FY2023Mar 31, 2023$24.13B-12.6%
Q4 FY2022Dec 31, 2022$25.86B+4.8%
Q3 FY2022Sep 30, 2022$26.06B+24.5%
Q2 FY2022Jun 30, 2022$26.04B+61.2%
Q1 FY2022Mar 31, 2022$27.61B+117.5%
Q4 FY2021Dec 31, 2021$24.67B+236.2%
Q3 FY2021Sep 30, 2021$20.92B+349.9%
Q2 FY2021Jun 30, 2021$16.15B+363.4%
Q1 FY2021Mar 31, 2021$12.69B+514.0%
Q4 FY2020Dec 31, 2020$7.34B+361.6%
Q3 FY2020Sep 30, 2020$4.65B+192.3%
Q2 FY2020Jun 30, 2020$3.49B+106.9%
Q1 FY2020Mar 31, 2020$2.07B+14.5%
Q4 FY2019Dec 31, 2019$1.59B-19.0%
Q3 FY2019Sep 30, 2019$1.59B+46.7%
Q2 FY2019Jun 30, 2019$1.69B–
Q1 FY2019Mar 31, 2019$1.81B–
Q4 FY2018Dec 31, 2018$1.96B–
Q4 FY2017Dec 31, 2017$1.08B–

More Moderna figures

See a number that looks wrong?